Could a simple blood test tell us more about fever seizures in kids?
NCT ID NCT07660003
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether children who have seizures with fever show signs of DNA damage in their blood. Researchers measure a substance called 8-OHdG, which is a marker of oxidative stress, in children with simple or complex febrile seizures and compare it to healthy children. The goal is to see if this marker can help tell the difference between seizure types. It is an early, exploratory study and not yet ready for use in clinics.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If 8-OHdG levels differ between simple and complex febrile seizures, it could point toward a blood test to help classify seizure types.
What could go wrong
This is a small, exploratory study measuring a single biomarker at one time point. The findings may not be strong enough to guide diagnosis or treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FEBRILE SEIZURES SIMPLE FEBRILE SEIZURE COMPLEX FEBRILE SEIZURE; OXIDATIVE STRESS; OXIDATIVE DNA DAMAGE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kayseri City Hospital
Kayseri, 38090, Turkey (Türkiye)